(Q54254954)
Statements
Synergistic antitumor effects of combination immunotherapy with recombinant interleukin-2 and a recombinant hybrid alpha-interferon in the treatment of established murine hepatic metastases. (English)
1 reference
Rosenberg SA
1 reference
Cameron RB
1 reference
McIntosh JK
1 reference
1 October 1988
1 reference
1 reference
48
1 reference
5810-5817
1 reference
20
1 reference
Identifiers
1 reference